Web of Science: 0 cites, Scopus: 0 cites, Google Scholar: cites
Correlation of MR-Based Metabolomics and Molecular Profiling in the Tumor Microenvironment of Temozolomide-Treated Orthotopic GL261 Glioblastoma in Mice
Zhao, Kai (Philipps University Marburg)
Calero-Perez, Pilar (Institut d'Investigació Biomèdica Sant Pau)
Bopp, Miriam H.A. (Center for Mind. Brain and Behavior (CMBB))
Möschl, Vincent (Philipps University Marburg)
Pagenstecher, Axel (Philipps-University Marburg)
Mulero-Acevedo, Marta (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Vázquez, Mario (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Barcia, Carlos (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Arús i Caraltó, Carles (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Nimsky, Christopher (Center for Mind. Brain and Behavior (CMBB))
Rusch, Tillmann (Philipps University Marburg)
Bartsch, Joerg Walter. (Center for Mind. Brain and Behavior (CMBB))
Candiota Silveira, Ana Paula (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)

Data: 2023
Resum: The tumor microenvironment in glioblastoma (GB) is considered to be "cold", i. e. , the fraction of cytotoxic T cells, for instance, is low. Instead, macrophages are the major immune cell population in GB, which stem either from tissue response (resident microglia) or recruitment of macrophages from the periphery, thereby undergoing tumor-dependent "imprinting" mechanisms by which macrophages can adapt a tumor-supportive phenotype. In this regard, it is important to describe the nature of macrophages associated with GB, in particular under therapy conditions using the gold standard chemotherapy drug temozolomide (TMZ). Here, we explored the suitability of combining information from in vivo magnetic resonance spectroscopic (MRS) approaches (metabolomics) with in vitro molecular analyses to assess therapy response and characterize macrophage populations in mouse GB using an isogenic GL261 model. For macrophage profiling, expression levels of matrix metalloproteinases (MMPs) and A disintegrin and metalloproteinases (ADAMs) were determined, since their gene products affect macrophage-tumor cell communication by extensive cleavage of immunomodulatory membrane proteins, such as PD-L1. In tumor mice with an overall therapy response, expression of genes encoding the proteases ADAM8, ADAM10, and ADAM17 was increased and might contribute to the immunosuppressive phenotype of GB and immune cells. In tumors responding to therapy, expression levels of ADAM8 were upregulated by TMZ, and higher levels of PD-L1 were correlated significantly. Using a CRISPR/Cas9 knockout of ADAM8 in GL261 cells, we demonstrated that soluble PD-L1 (sPD-L1) is only generated in the presence of ADAM8. Moreover, primary macrophages from WT and ADAM8-deficient mice showed ADAM8-dependent release of sPD-L1, independent of the macrophage polarization state. Since ADAM8 expression is induced in responding tumors and PD-L1 shedding is likely to decrease the anti-tumor activities of T-cells, we conclude that immunotherapy resistance is caused, at least in part, by the increased presence of proteases, such as ADAM8.
Ajuts: Agencia Estatal de Investigación PID2021-128717OB-I00
Ministerio de Sanidad y Consumo CB06/01/0010
Drets: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Llengua: Anglès
Document: Article ; recerca ; Versió publicada
Matèria: MR spectroscopic imaging ; PD-L1 ; Glioblastoma ; Macrophages ; Metalloproteases ; Shedding ; Temozolomide ; Therapy
Publicat a: International journal of molecular sciences, Vol. 24 Núm. 24 (december 2023) , p. 17628, ISSN 1422-0067

DOI: 10.3390/ijms242417628
PMID: 38139457


24 p, 4.7 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats

 Registre creat el 2024-02-12, darrera modificació el 2024-05-18



   Favorit i Compartir